Ciby Abraham, PhD

AstraZeneca
Senior Director and Group Manager, Project and Product Leadership
Ciby Abraham is a Senior Director and Group Manager, Project and Product Leadership in CMC Regulatory Affairs at AstraZeneca. Prior to his role with AstraZeneca, Ciby worked at the FDA as a review chemist and a quality assessment lead. In addition, Ciby worked in the industry as a formulator, analytical method development scientist, and a manufacturing specialist. He was also licensed by the New York State Board of Pharmacy to release compounded products to the market.

Ciby holds a Ph.D. in chemistry from Johns Hopkins University, Master’s degree in chemistry from St. John’s University, and a Bachelor’s degree in chemistry from Binghamton University.

Related Articles

Regulatory, Compliance and Quality Challenges, Learnings, and Future Opportunities
iSpeak Blog
Regulatory, Compliance and Quality Challenges, Learnings, and Future Opportunities

The pharmaceutical industry is constantly evolving, placing a significant emphasis on emerging technologies that facilitate quicker access of medications for patients globally. This unceasing drive for innovation and improvement has led the industry to embrace cutting-edge technologies like data analytics, machine learning, and artificial intelligence. These technologies are not just trends;...

Quality and Regulatory Challenges, Learnings, and Future Opportunities
iSpeak Blog
Quality and Regulatory Challenges, Learnings, and Future Opportunities

While everyone is facing new speed to market expectations, we should consider and discuss why global regulatory barriers are increasing, why science- and risk-based strategies often mean more data are required, and why regulatory approval for new technologies and new medicines seems more challenging than ever before. We can no longer afford to delay innovation, product and process...